Reading Time: 2 minutesIntroduction Epilepsy, a chronic neurological disorder characterized by recurrent seizures, poses significant challenges to pediatric patients, particularly in terms of growth and development. Saizen, a recombinant human growth hormone, has been explored as a therapeutic option to address these challenges. This article delves into the efficacy of Saizen therapy in children with epilepsy, focusing on its impact on growth and seizure control, specifically tailored to the American male demographic. Understanding Epilepsy in Children Epilepsy affects approximately 470,000 children in the United States, with a higher prevalence among boys. The condition can lead to growth retardation due to the metabolic demands … Continue reading →